Onyx leads declines in biotech stocks By: MarketWatch May 19, 2011 at 11:19 AM EDT Shares of Onyx Pharmaceuticals are falling after it released data from a Phase II study for its drug Nexavar in the treatment of breast cancer. Read More >> Related Stocks: Bayer Aktienges ADR